Skip to main navigation Skip to search Skip to main content

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

  • Juan F. Gallegos-Orozco
  • , Kristina T. Werner
  • , Marianne Rosati
  • , Thomas J. Byrne
  • , Vijayan Balan
  • , Hugo E. Vargas
  • , Jorge Rakela

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2161-2162
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume103
Issue number8
DOIs
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this